LWLG 10-Q Quarterly Report March 31, 2013 | Alphaminr
Lightwave Logic, Inc.

LWLG 10-Q Quarter ended March 31, 2013

LIGHTWAVE LOGIC, INC.
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
10-Q 1 lwlg033113_10q.htm QUARTERLY REPORT ON FORM 10-Q Form 10Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

FORM 10-Q

____________________

(Mark One)


ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2013

OR

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________to _____________


Commission File Number 0-52567


Lightwave Logic, Inc.

(Exact name of registrant as specified in its charter)


Nevada

(State or other jurisdiction of
Incorporation or Organization)

82-049-7368

(I.R.S. Employer Identification No.)


111 Ruthar Drive
Newark, DE
(Address of principal executive offices)

__19711 ____
(Zip Code)

(302) 356-2717

(Registrant’s telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.                     Yes x No ¨


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).            Yes x No ¨





Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act (Check one):


Large accelerated filer

¨

Accelerated filer

¨

Non-accelerated filer

¨

Smaller reporting company

x


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)                    Yes ¨ No x


The number of shares of the registrant s Common Stock outstanding as of May 15, 2013 was 51,826,797










TABLE OF CONTENTS

PART I FINANCIAL INFORMATION


Page

Part I

Financial Information

2

Item 1

Financial Statements

2

Item 2

Management’s Discussion and Analysis of Financial
Condition and Results of Operations

25

Item 4

Controls and Procedures

40

Part II

Other Information

40

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

40

Item 6

Exhibits

41

Signatures

42





-1-





PART I – FINANCIAL INFORMATION



Item 1

Financial Information



-2-















LIGHTWAVE LOGIC, INC.

(A Development Stage Company)


FINANCIAL STATEMENTS


MARCH 31, 2013


(UNAUDITED)

























-3-










CONTENTS


PAGE

BALANCE SHEETS

1

STATEMENTS OF OPERATIONS

2

STATEMENT OF STOCKHOLDERS’ EQUITY

3 – 9

STATEMENTS OF CASH FLOWS

10 – 11

NOTES TO FINANCIAL STATEMENTS

12 – 17





-4-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

BALANCE SHEETS







March 31, 2013

December 31, 2012

(Unaudited)

(Audited)

ASSETS

CURRENT ASSETS

Cash and cash equivalents

$

3,319,258

$

2,936,879

Prepaid expenses

75,107

89,975

3,394,365

3,026,854

PROPERTY AND EQUIPMENT - NET

364,752

300,994

OTHER ASSETS

Intangible assets - net

495,533

488,526

TOTAL ASSETS

$

4,254,650

$

3,816,374

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES

Accounts payable

$

125,451

$

96,384

Accounts payable and accrued expenses- related parties

75,787

55,606

Accrued expenses

9,738

3,338

TOTAL LIABILITIES

210,976

155,328

STOCKHOLDERS' EQUITY

Preferred stock, $0.001 par value, 1,000,000 authorized

No shares issued or outstanding

-

-

Common stock $0.001 par value, 100,000,000 authorized

51,097,728 and 50,160,758 issued and outstanding at

March 31, 2013 and December 31, 2012

51,099

50,161

Additional paid-in-capital

33,346,912

32,042,751

Accumulated deficit

(15,827)

(15,827)

Deficit accumulated during development stage

(``,338,510)

(28,416,039)

TOTAL STOCKHOLDERS' EQUITY

4,043,674

3,661,046

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$

4,254,650

$

3,816,374





See accompanying notes to these financial statements.


-5-



LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

STATEMENTS OF OPERATIONS FOR THE THREE MONTHS ENDING MARCH 31, 2013 AND 2012 AND FOR THE PERIOD

JANUARY 1, 2004 (INCEPTION OF DEVELOPMENT STAGE) TO MARCH 31, 2013

(UNAUDITED)






Cumulative

For the Three

For the Three

Since

Months Ending

Months Ending

Inception

March 31, 2013

March 31, 2012

NET SALES

$

3,200

$

-

$

-

COST AND EXPENSE

Research and development

13,609,570

455,382

472,409

General and administrative

15,369,185

447,618

297,190

28,978,755

903,000

769,599

LOSS FROM OPERATIONS

(28,975,555)

(903,000)

(769,599)

OTHER INCOME (EXPENSE)

Interest income

31,125

79

198

Dividend income

1,551

-

-

Realized gain on investment

3,911

-

-

Realized gain on disposal of assets

637

-

-

Litigation settlement

(47,500)

-

-

Commitment fee and interest expense

(352,679)

(19,550)

(101,945)

NET LOSS

$

(29,338,510)

$

(922,471)

$

(871,346)

Basic and Diluted Loss per Share

$

(0.02)

$

(0.02)

Basic and Diluted Weighted Average Number of Shares

50,461,598

46,732,009




See accompanying notes to these financial statements.


-6-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE PERIOD JANUARY 1, 2004 (INCEPTION OF DEVELOPMENT STAGE) TO MARCH 31, 2013

(UNAUDITED)








Subscription

Receivable/

Deficit

Receivable

Unrealized

Accumulated

Number of

Common

Paid-in

for Issuance

Deferred

Loss

Accumulated

During

Shares

Stock

Capital

of Common Stock

Charges

on Securities

Deficit

Development Stage

Total

ENDING BALANCE AT DECEMBER 31, 2003

100

$

1

$

-

$

-

$

-

$

-

$

(15,827)

$

-

$

(15,826)

Retroactive recapitalization upon reverse acquisition

706,973

706

(706)

-

-

-

-

-

-

BALANCE AT JANUARY 1, 2004

707,073

707

(706)

-

-

-

(15,827)

-

(15,826)

Common stock issued to founders

13,292,927

13,293

(13,293)

-

-

-

-

-

-

Common stock issued for future services in July 2004 at $0.16/share

1,600,000

1,600

254,400

-

-

-

-

-

256,000

Common stock issued at merger

2,000,000

2,000

(2,000)

-

-

-

-

-

-

Common stock issued for future services in August 2004 at $0.12/share

637,500

638

74,362

-

-

-

-

-

75,000

Conversion of note payable in December 2004 at $0.16/share

187,500

187

29,813

-

-

-

-

-

30,000

Net loss for the year ended December 31, 2004

-

-

-

-

-

-

-

(722,146)

(722,146)

BALANCE AT DECEMBER 31, 2004

18,425,000

18,425

342,576

-

-

-

(15,827)

(722,146)

(376,972)

Common stock issued in private placement in April 2005 at $0.25/share

4,000,000

4,000

996,000

-

-

-

-

-

1,000,000

Conversion of notes payable in May 2005 at $0.16/share

3,118,750

3,119

495,881

-

-

-

-

-

499,000

Subscription receivable

-

-

-

(6,500)

-

-

-

-

(6,500)

Common stock issued for future services in August 2005, valued at $2.79/share

210,000

210

585,290

-

-

-

-

-

585,500

Common stock issued for future services in August 2005, valued at $2.92/share

200,000

200

583,800

-

-

-

-

-

584,000

Warrants issued for services in May 2005, vested during 2005, valued at $1.13/share

-

-

37,000

-

-

-

-

-

37,000

Warrants issued for services in September 2005, vested during 2005, valued at $1.45/share

-

-

24,200

-

-

-

-

-

24,200

Warrants issued for services in October 2005, vested during 2005, valued at $0.53/share

-

-

15,900

-

-

-

-

-

15,900

Warrants issued for future services in December 2005, vested during 2005,  valued at $1.45/share

-

-

435,060

-

-

-

-

-

435,060

Deferred charges for common stock issued for future services in August 2005, valued at $2.92/share

-

-

-

-

(584,000)

-

-

-

(584,000)

Amortization of deferred charges

-

-

-

-

265,455

-

-

-

265,455

Exercise of warrants in December 2005 at $0.25/share

300,000

300

74,700

-

-

-

-

-

75,000

Net loss for the year ended December 31, 2005

-

-

-

-

-

-

-

(1,721,765)

(1,721,765)

BALANCE AT DECEMBER 31, 2005

26,253,750

26,254

3,590,407

(6,500)

(318,545)

-

(15,827)

(2,443,911)

831,878

Common stock issued in private placement during 2006 at $0.50/share

850,000

850

424,150

-

-

-

-

-

425,000

Common stock issued for future services in February 2006, valued at $0.90/share

300,000

300

269,700

-

-

-

-

-

270,000

Common stock issued for future services in May 2006, valued at $1.55/share

400,000

400

619,600

-

-

-

-

-

620,000

Common stock issued for future services in June 2006, valued at $1.45/share

25,000

25

36,225

-

-

-

-

-

36,250

Common stock issued for future services in November 2006, valued at $0.49/share

60,000

60

29,340

-

-

-

-

-

29,400

Warrants issued for services in September 2005, vested during 2006, valued at $1.45/share

-

-

66,500

-

-

-

-

-

66,500

Warrants issued for future services in June 2006, vested during 2006, valued at $1.55/share

-

-

465,996

-

-

-

-

-

465,996

Options issued for services in February 2006, vested during 2006, valued at $1.01/share

-

-

428,888

-

-

-

-

-

428,888

Contributed capital related to accrued interest

-

-

35,624

-

-

-

-

-

35,624

Subscription receivable

-

-

-

6,500

-

-

-

-

6,500

Amortization of deferred charges

-

-

-

-

318,545

-

-

-

318,545

Unrealized gain (loss) on securities

-

-

-

-

-

(26,000)

-

-

(26,000)

Net loss for the year ending December 31, 2006

-

-

-

-

-

-

(2,933,809)

(2,933,809)

BALANCE AT DECEMBER 31, 2006

27,888,750

$

27,889

$

5,966,430

$

-

$

-

$

(26,000)

$

(15,827)

$

(5,377,720)

$

574,772



See accompanying notes to these financial statements.


-7-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE PERIOD JANUARY 1, 2004 (INCEPTION OF DEVELOPMENT STAGE) TO MARCH 31, 2013 (CONTINUED)

(UNAUDITED)






Subscription

Receivable/

Deficit

Receivable

Unrealized

Accumulated

Number of

Common

Paid-in

for Issuance

Deferred

Loss

Accumulated

During

Shares

Stock

Capital

of Common Stock

Charges

on Securities

Deficit

Development Stage

Total

BALANCE AT DECEMBER 31, 2006

27,888,750

$

27,889

$

5,966,430

$

-

$

-

$

(26,000)

$

(15,827)

$

(5,377,720)

$

574,772

Common stock issued in private placement during 2007 at $0.50/share

2,482,000

2,482

1,238,518

-

-

-

-

-

1,241,000

Common stock issued in private placement during 2007 at $0.60/share

1,767,540

1,768

1,058,756

-

-

-

-

-

1,060,524

Common stock subscription rescinded during 2007 at $0.50/share

(400,000)

(400)

(199,600)

-

-

-

-

-

(200,000)

Common stock issued for future services in February 2007, valued at $0.70/share

151,785

152

106,098

-

-

-

-

-

106,250

Common stock issued for future services in March 2007, valued at $0.58/share

1,000,000

1,000

579,000

-

-

-

-

-

580,000

Common stock issued for services and settlement for accounts payable in April 2007, valued at $0.35/share

100,000

100

34,900

35,000

Common stock issued for services in October 2007, valued at $0.68/share

150,000

150

101,850

-

-

-

-

-

102,000

Common stock issued for services in October 2007, valued at $0.90/share

150,000

150

134,850

-

-

-

-

-

135,000

Common stock issued for services in November 2007, valued at $0.72/share

400,000

400

287,600

-

-

-

-

-

288,000

Warrants issued for services in September 2005, vested during 2007, valued at $1.45/share

-

-

36,370

-

-

-

-

-

36,370

Warrants issued for services in March 2007, vested during 2007, valued at $0.63/share

-

-

52,180

-

-

-

-

-

52,180

Warrants issued for services in April 2007, vested during 2007, valued at $0.69/share

-

-

293,476

-

-

-

-

-

293,476

Warrants issued for services in April 2007, vested during 2007, valued at $0.63/share

-

-

140,490

-

-

-

-

-

140,490

Warrants issued for services in May 2007, vested during 2007, valued at $0.56/share

-

-

52,946

-

-

-

-

-

52,946

Warrants issued for services in October 2007, vested during 2007, valued at $0.61/share

-

-

61,449

-

-

-

-

-

61,449

Warrants issued for services in October 2007, vested during 2007, valued at $0.78/share

-

-

52,292

-

-

-

-

-

52,292

Warrants issued for services in December 2007, vested during 2007, valued at $0.55/share

-

-

1,159

-

-

-

-

-

1,159

Options issued for services in February 2006, vested during 2007, valued at $1.01/share

-

-

17,589

-

-

-

-

-

17,589

Options issued for services in February 2006, vested during 2007, valued at $1.09/share

-

-

43,757

-

-

-

-

-

43,757

Options issued for services in November 2007, vested during 2007, valued at $0.60/share

-

-

41,653

-

-

-

-

-

41,653

Warrants issued for future services in April 2007, vested during 2007, valued at $0.70/share

-

-

348,000

-

-

-

-

-

348,000

Deferred charges for common stock issued for future services in March 2007,  valued at $0.58/share

-

-

-

-

(928,000)

-

-

-

(928,000)

Amortization of deferred charges

-

-

-

-

773,333

-

-

-

773,333

Unrealized gain (loss) on securities

-

-

-

-

-

(32,610)

-

-

(32,610)

Net loss for the year ending December 31, 2007

-

-

-

-

-

-

-

(4,223,449)

(4,223,449)

BALANCE AT DECEMBER 31, 2007

33,690,075

33,690

10,449,763

-

(154,667)

(58,610)

(15,827)

(9,601,169)

653,180

Common stock issued in private placement during 2008 at $0.60/share

690,001

690

413,310

-

-

-

-

-

414,000

Common stock issued for services in March 2008, valued at $0.75/share

100,000

100

74,900

-

-

-

-

-

75,000

Common stock issued for services in August 2008, valued at $1.80/share

200,000

200

359,800

-

-

-

-

-

360,000

Exercise of warrants at $0.25/share

320,000

320

79,680

-

-

-

-

-

80,000

Exercise of warrants at $0.25/share, pursuant to November 2008 adjusted stock offering

641,080

641

159,629

160,270

Exercise of warrants at $0.50/share

270,000

270

134,730

-

-

-

-

-

135,000

Warrants issued for services in September 2005, vested during 2008, valued at $1.45/share

-

-

27,014

-

-

-

-

-

27,014

Warrants issued for services in March 2007, vested during 2008, valued at $0.63/share

-

-

10,885

-

-

-

-

-

10,885

Warrants issued for services in April 2007, vested during 2008, valued at $0.69/share

-

-

121,713

-

-

-

-

-

121,713

Warrants issued for services in April 2007, vested during 2008, valued at $0.63/share

-

-

48,738

-

-

-

-

-

48,738

Warrants issued for services in May 2007, vested during 2008, valued at $0.56/share

-

-

31,444

-

-

-

-

-

31,444

Warrants issued for services in December 2007, vested during 2008, valued at $0.55/share

-

-

12,487

-

-

-

-

-

12,487

Options issued for services in November 2007, vested during 2008, valued at $0.60/share

-

-

286,803

-

-

-

-

-

286,803

Options issued for services in January 2008, vested during 2008, valued at $0.60/share

-

-

30,750

-

-

-

-

-

30,750

Options issued for services in July 2008, vested during 2008, valued at $1.48/share

-

-

114,519

-

-

-

-

-

114,519

Options issued for services in August 2008, vested during 2008, valued at $1.36/share

-

-

525,263

-

-

-

-

-

525,263

Options issued for services in November 2008, vested during 2008, valued at $0.50/share

-

-

6,439

-

-

-

-

-

6,439

Warrants issued for future services in March 2008, vested through September 2008,  valued at $0.83/share

-

-

332,000

-

(332,000)

-

-

-

-

Warrants issued for services in May 2008, vested through September 2008, valued at $1.63/share

-

-

976,193

-

-

-

-

-

976,193

Amortization of deferred charges

-

-

-

-

431,337

-

-

-

431,337

Receivable for the issuance of common stock

-

-

-

(12,500)

-

-

-

-

(12,500)

Realized loss reclassification

-

-

-

-

-

58,610

-

-

58,610

Net loss for the year ending December 31, 2008

-

-

-

-

-

-

-

(4,340,607)

(4,340,607)

BALANCE AT DECEMBER 31, 2008

35,911,156

$

35,911

$

14,196,060

$

(12,500)

$

(55,330)

$

-

$

(15,827)

$

(13,941,776)

$

206,538



See accompanying notes to these financial statements.


-8-



LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE PERIOD JANUARY 1, 2004 (INCEPTION OF DEVELOPMENT STAGE) TO MARCH 31, 2013 (CONTINUED)

(UNAUDITED)






Subscription

Receivable/

Deficit

Receivable

Unrealized

Accumulated

Number of

Common

Paid-in

for Issuance

Deferred

Loss

Accumulated

During

Shares

Stock

Capital

of Common Stock

Charges

on Securities

Deficit

Development Stage

Total

BALANCE AT DECEMBER 31, 2008

35,911,156

$

35,911

$

14,196,060

$

(12,500)

$

(55,330)

$

-

$

(15,827)

$

(13,941,776)

$

206,538

Rights to purchase shares issued in January 2009, vested during 2009, valued at $0.33/share

-

-

132,058

-

-

-

-

-

132,058

Common stock issued for services in January 2009, valued at $0.58/share

100,000

100

57,900

-

-

-

-

-

58,000

Common stock issued for services & settlement for accounts payable January 2009 valued at $0.25/share

100,000

100

24,900

-

-

-

-

-

25,000

Exercise of purchase right agreement in January 2009 at $0.25/share

180,550

181

44,957

-

-

-

-

-

45,138

Exercise of warrants at $0.25/share, pursuant to November 2008 adjusted stock offering

1,279,336

1,279

318,555

-

319,834

Exercise of warrants at $0.001/share

400,000

400

-

-

-

-

-

-

400

Exercise of warrants at $1.00/share

355,000

355

354,645

-

355,000

Options issued for services in November 2007, vested during 2009, valued at $0.60/share

-

-

199,234

-

-

-

-

-

199,234

Options issued for services in January 2008, vested during 2009, valued at $0.60/share

-

-

13,583

-

-

-

-

-

13,583

Options issued for services in July 2008, vested during 2009, valued at $1.48/share

-

-

67,838

-

-

-

-

-

67,838

Options issued for services in August 2008, vested during 2009, valued at $1.36/share

-

-

623,246

-

-

-

-

-

623,246

Options issued for services in November 2008, vested during 2009, valued at $0.50/share

-

-

61,346

-

-

-

-

-

61,346

Options issued for services in January 2009, vested during 2009, valued at $0.53/share

-

-

13,136

-

-

-

-

-

13,136

Options issued for services in February 2009, vested during 2009, valued at $0.38/share

-

-

9,583

-

-

-

-

-

9,583

Options issued for services in June 2009, vested during 2009, valued at $0.85/share

-

-

21,085

-

-

-

-

-

21,085

Warrants issued for services in June 2009, vested during 2009, valued at $0.85/share

-

-

177,881

-

-

-

-

-

177,881

Contribution of accrued payroll in February 2009

-

-

52,129

-

-

-

-

-

52,129

Amortization of deferred charges

-

-

-

-

55,330

-

-

-

55,330

Payment for the issuance of common stock

-

-

-

12,500

-

-

-

-

12,500

Common stock issued for services in June 2009, valued at $0.34/share

116,000

116

39,884

-

-

-

-

-

40,000

Common stock issued for services & settlement for accounts payable June 2009 valued at $0.34/share

145,000

145

49,855

-

-

-

-

-

50,000

Common stock issued in private placement during June 2009 at $0.34/share

2,479,500

2,480

852,520

-

-

-

-

-

855,000

Common stock issued for services in July 2009, valued at $0.75/share

100,000

100

74,900

-

-

-

-

-

75,000

Net loss for the year ending December 31, 2009

-

-

-

-

-

-

-

(2,721,871)

(2,721,871)

BALANCE AT December 31, 2009

41,166,542

41,167

17,385,295

-

-

-

(15,827)

(16,663,647)

746,988

-

Options issued for services in November 2007, vested during 2010, valued at $0.60/share

-

-

174,866

-

-

-

-

174,866

Options issued for services in January 2008, vested during 2010, valued at $0.60/share

-

-

14,873

-

-

-

-

-

14,873

Options issued for services in July 2008, vested during 2010, valued at $1.48/share

-

-

74,061

-

-

-

-

-

74,061

Options issued for services in August 2008, vested during 2010, valued at $1.36/share

-

-

643,812

-

-

-

-

-

643,812

Options issued for services in November 2008, vested during 2010, valued at $0.50/share

-

-

31,478

-

-

-

-

-

31,478

Warrants issued for services in June 2009, vested during 2010, valued at $0.85/share

-

-

213,459

-

-

-

-

-

213,459

Warrants issued for services in January 2010, vested during 2010, valued at $1.83/share

580,167

-

580,167

Warrants issued for services in March 2010, vested during 2010, valued at $1.86/share

-

-

214,063

-

-

-

-

-

214,063

Options issued for services in August 2010, vested during 2010, valued at $1.31/share

-

-

27,434

-

-

-

-

-

27,434

Options issued for services in December 2010, vested during 2010, valued at $1.14/share

-

-

286,002

-

-

-

-

-

286,002

Exercise of warrants at $0.25/share

947,200

947

235,853

-

-

-

-

-

236,800

Exercise of options at $0.25/share

15,000

15

3,735

-

-

-

-

-

3,750

Exercise of warrants at $0.345/share

10,000

10

3,440

-

-

-

-

-

3,450

Exercise of warrants at $0.50/share

25,000

25

12,475

-

-

-

-

-

12,500

Exercise of warrants at $1.00/share

282,500

283

282,218

-

-

-

-

-

282,500

Common stock issued in private placement during 2010 at $1.00/share

1,500,000

1,500

1,498,500

-

-

-

-

-

1,500,000

Common stock issued for services in August 2010, valued at $1.25/share

4,800

4

5,996

-

-

-

-

-

6,000

Common stock issued for services in November 2010, valued at $0.93/share

5,000

5

4,645

-

-

-

-

-

4,650

Common stock issued for services in December 2010, valued at $01.20/share

10,000

10

11,990

-

-

-

-

-

12,000

Net loss for the year ending December 31, 2010

-

-

-

-

-

-

-

(3,713,232)

(3,713,232)


BALANCE AT DECEMBER 31, 2010

43,966,042

$

43,966

$

21,704,361

$

-

$

-

$

-

$

(15,827)

$

(20,376,879)

$

1,355,621




See accompanying notes to these financial statements.


-9-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE PERIOD JANUARY 1, 2004 (INCEPTION OF DEVELOPMENT STAGE) TO MARCH 31, 2013 (CONTINUED)

(UNAUDITED)




Subscription

Receivable/

Receivable

Deficit Accumulated

Number of

Common

Paid-in

for Issuance

Deferred

Unrealized Loss

Accumulated

During

Shares

Stock

Capital

of Common Stock

Charges

on Securities

Deficit

Development Stage

Total

BALANCE AT DECEMBER 31, 2010

43,966,042

$ 43,966

$ 21,704,361

$ -

$ -

$ -

$ (15,827)

$ (20,376,879)

$ 1,355,621

Common stock issued for services in March 2011, valued at $1.45/share

10,000

10

14,490

-

-

-

-

-

14,500

Options issued for services in January 2008, vested during 2011, valued at $0.60/share

-

-

285

-

-

-

-

-

285

Options issued for services in July 2008, vested during 2011, valued at $1.48/share

-

-

39,829

-

-

-

-

-

39,829

Options issued for services in August 2008, vested during 2011, valued at $1.36/share

-

-

383,881

-

-

-

-

-

383,881

Options issued for services in November 2008, vested during 2011, valued at $0.50/share

-

-

26,648

-

-

-

-

-

26,648

Warrants issued for services in January 2010, vested during 2011, valued at $1.83/share

-

-

306,765

-

-

-

-

-

306,765

Warrants issued for services in March 2010, vested during 2011, valued at $1.86/share

-

-

64,983

-

-

-

-

-

64,983

Options issued for services in August 2010, vested during 2011, valued at $1.31/share

-

-

65,447

-

-

-

-

-

65,447

Options issued for services in December 2010, vested during 2011, valued at $1.14/share

-

-

212,136

-

-

-

-

-

212,136

Warrants issued for services in January 2011, vested during 2011, valued at $1.05/share

-

-

36,585

-

-

-

-

-

36,585

Warrants issued for services in April 2011, vested during 2011, valued at $0.98/share

-

-

109,820

-

-

-

-

-

109,820

Options issued for services in May 2011, vested during 2011, valued at $0.97/share

-

-

79,702

-

-

-

-

-

79,702

Options issued for services in August 2011, vested during 2011, valued at $0.82/share

-

-

17,204

-

-

-

-

-

17,204

Options issued for services in November 2011, vested during 2011, valued at $0.53/share

-

-

4,384

-

-

-

-

-

4,384

Options issued for services in December 2011, vested during 2011, valued at $0.82/share

-

-

53,124

-

-

-

-

-

53,124

Warrants issued for services in December 2011, vested during 2011, valued at $1.05/share

-

-

1,288

-

-

-

-

-

1,288

Common stock issued for commitment shares, valued at $1.08/share

150,830

151

162,746

-

-

-

-

-

162,896

Common stock issued to institutional investor, valued at $1.08/share

185,185

185

199,815

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.15/share

3,017

3

3,467

-

-

-

-

-

3,470

Common stock issued for services in June 2011, valued at $1.04/share

10,000

10

10,390

-

-

-

-

-

10,400

Common stock issued in private placement during 2011 at $1.00/share

1,000,000

1,000

999,000

-

-

-

-

-

1,000,000

Common stock issued for services in September 2011, valued at $1.45/share

10,000

10

14,490

-

-

-

-

-

14,500

Common stock issued for services in May 2011 through August 2011, valued at $0.90/share to $1.25/share

2,018

2

2,161

-

-

-

-

-

2,163

Net loss for the year ending December 31, 2011

-

-

-

-

-

-

-

(3,482,622)

(3,482,622)

BALANCE AT DECEMBER 31, 2011

45,337,092

$ 45,337

$ 24,513,000

$ -

$ -

$ -

$ (15,827)

$ (23,859,501)

$ 683,009






See accompanying notes to these financial statements.


-10-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE PERIOD JANUARY 1, 2004 (INCEPTION OF DEVELOPMENT STAGE) TO MARCH 31, 2013 (CONTINUED)

(UNAUDITED)






Subscription

Receivable/

Deficit

Receivable

Unrealized

Accumulated

Number of

Common

Paid-in

for Issuance

Deferred

Loss

Accumulated

During

Shares

Stock

Capital

of Common Stock

Charges

on Securities

Deficit

Development Stage

Total

BALANCE AT DECEMBER 31, 2011

45,337,092

$

45,337

$

24,513,000

$

-

$

-

$

-

$

(15,827)

$

(23,859,501)

$

683,009

Common stock issued to institutional investor, valued at $1.013/share

197,433

198

199,802

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.64/share

3,017

3

4,945

-

-

-

-

-

4,948

Common stock issued to institutional investor, valued at $1.197/share

167,084

167

199,832

-

-

-

-

-

199,999

Common stock issued for additional commitment shares, valued at $1.67/share

3,017

3

5,035

-

-

-

-

-

5,038

Common stock issued to institutional investor, valued at $1.58/share

316,455

317

499,682

-

-

-

-

-

499,999

Common stock issued for additional commitment shares, valued at $2.87/share

7,542

7

21,638

-

-

-

-

-

21,645

Common stock issued to institutional investor, valued at $1.66/share

120,482

120

199,880

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.97/share

3,017

3

5,940

-

-

-

-

-

5,943

Common stock issued to institutional investor, valued at $1.897/share

158,144

158

299,841

-

-

-

-

-

299,999

Common stock issued for additional commitment shares, valued at $2.60/share

4,525

5

11,760

-

-

-

-

-

11,765

Common stock issued to institutional investor, valued at $2.073/share

96,479

97

199,904

-

-

-

-

-

200,001

Common stock issued for additional commitment shares, valued at $2.64/share

3,017

3

7,962

-

-

-

-

-

7,965

Common stock issued to institutional investor, valued at $2.19/share

91,324

92

199,908

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $2.23/share

3,017

3

6,725

-

-

-

-

-

6,728

Common stock issued to institutional investor, valued at $1.68/share

119,048

119

199,882

-

-

-

-

-

200,001

Common stock issued for additional commitment shares, valued at $1.80/share

3,017

3

5,428

-

-

-

-

-

5,431

Common stock issued to institutional investor, valued at $1.81/share

220,994

221

399,778

-

-

-

-

-

399,999

Common stock issued for additional commitment shares, valued at $1.88/share

3,017

3

5,669

-

-

-

-

-

5,672

Common stock issued for additional commitment shares, valued at $1.92/share

3,017

3

5,790

-

-

-

-

-

5,793

Common stock issued to institutional investor, valued at $1.53/share

130,719

131

199,870

-

-

-

-

-

200,001

Common stock issued for additional commitment shares, valued at $1.60/share

3,017

3

4,824

-

-

-

-

-

4,827

Common stock issued to institutional investor, valued at $1.667/share

119,976

120

199,880

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.93/share

3,017

3

5,820

-

-

-

-

-

5,823

Common stock issued to institutional investor, valued at $1.51/share

132,450

132

199,867

-

-

-

-

-

199,999

Common stock issued for additional commitment shares, valued at $1.70/share

6,034

6

10,252

-

-

-

-

-

10,258

Common stock issued to institutional investor, valued at $1.677/share

119,261

119

199,882

-

-

-

-

-

200,001

Common stock issued for additional commitment shares, valued at $1.35/share

3,017

3

4,070

-

-

-

-

-

4,073

Common stock issued to institutional investor, valued at $1.13/share

176,991

177

199,823

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.28/share

3,017

3

3,859

-

-

-

-

-

3,862

Common stock issued to institutional investor, valued at $1.1267/share

177,510

178

199,823

-

-

-

-

-

200,001

Common stock issued for additional commitment shares, valued at $1.28/share

3,017

3

3,859

-

-

-

-

-

3,862

Common stock issued to institutional investor, valued at $1.107/share

180,668

180

199,820

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.18/share

3,017

3

3,557

-

-

-

-

-

3,560

Common stock issued to institutional investor, valued at $1.10/share

181,818

182

199,818

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.08/share

3,017

3

3,255

-

-

-

-

-

3,258

Common stock issued to institutional investor, valued at $1.063/share

188,147

188

199,812

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.09/share

3,017

3

3,286

-

-

-

-

-

3,289

Common stock issued to institutional investor, valued at $1.02/share

196,078

196

199,803

-

-

-

-

-

199,999

Common stock issued for additional commitment shares, valued at $1.04/share

1,508

2

1,566

-

-

-

-

-

1,568

Common stock issued to institutional investor, valued at $1.02/share

98,039

98

99,902

-

-

-

-

-

100,000

Common stock issued for additional commitment shares, valued at $1.10/share

2,262

2

2,486

-

-

-

-

-

2,488

Common stock issued to institutional investor, valued at $1.00/share

350,000

350

349,650

-

-

-

-

-

350,000

Common stock issued for additional commitment shares, valued at $1.00/share

3,017

3

3,014

-

-

-

-

-

3,017

Subtotal

48,949,352

$

48,950

$

29,490,199

$

-

$

-

$

-

$

(15,827)

$

(23,859,501)

$

5,663,821



See accompanying notes to these financial statements.


-11-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE PERIOD JANUARY 1, 2004 (INCEPTION OF DEVELOPMENT STAGE) TO MARCH 31, 2013 (CONTINUED)

(UNAUDITED)




Subscription

Receivable/

Deficit

Receivable

Unrealized

Accumulated

Number of

Common

Paid-in

for Issuance

Deferred

Loss

Accumulated

During

Shares

Stock

Capital

of Common Stock

Charges

on Securities

Deficit

Development Stage

Total

Subtotal

48,949,352

$

48,950

$

29,490,199

$

-

$

-

$

-

$

(15,827)

$

(23,859,501)

$

5,663,821

Exercise of options at $0.65/share

250,000

250

162,250

-

-

-

-

-

162,500

Exercise of warrants at $1.25/share

40,000

40

49,960

-

-

-

-

-

50,000

Exercise of warrants at $0.34/share

20,000

20

6,880

-

-

-

-

-

6,900

Exercise of warrants at $0.25/share

900,000

900

224,100

225,000

Common stock issued for services in October 2011 through January 2012,
valued at $0.65/share to $2.70/share

1,406

1

1,606

-

-

-

-

-

1,607

Options issued for services in August 2010, vested during 2012, valued at $1.31/share

-

-

38,194

-

-

-

-

-

38,194

Options issued for services in December 2010, vested during 2012, valued at $1.14/share

-

-

85,290

-

-

-

-

-

85,290

Warrants issued for services in April 2011, vested during 2012, valued at $0.98/share

-

-

36,605

-

-

-

-

-

36,605

Options issued for services in May 2011, vested during 2012, valued at $0.97/share

-

-

48,510

-

-

-

-

-

48,510

Options issued for services in August 2011, vested during 2012, valued at $0.82/share

-

-

41,156

-

-

-

-

-

41,156

Options issued for services in November 2011, vested during 2012, valued at $0.53/share

-

-

26,304

-

-

-

-

-

26,304

Options issued for services in December 2011, vested during 2012,  valued at $0.82/share

-

-

51,392

-

-

-

-

-

51,392

Warrants issued for services in December 2011, vested during 2012,  valued at $1.05/share

-

-

157,127

-

-

-

-

-

157,127

Options issued for services in March 2012, vested during 2012, valued at $1.37/share

-

-

139,755

-

-

-

-

-

139,755

Options issued for services in March 2012, vested during 2012, valued at $1.37/share

-

-

42,227

-

-

-

-

-

42,227

Warrants issued for services in March 2012, vested during 2012, valued at $1.37/share

-

-

13,709

-

-

-

-

-

13,709

Options issued for services in May 2012, vested during 2012, valued at $1.23/share

-

-

462,455

-

-

-

-

-

462,455

Warrants issued for services in May 2012, vested during 2012, valued at $0.97/share

-

-

55,648

-

-

-

-

-

55,648

Options issued for services in June 2012, vested during 2012, valued at $0.73/share

-

-

56,568

-

-

-

-

-

56,568

Options issued for services in August 2012, vested during 2012, valued at $0.74/share

-

-

15,611

-

-

-

-

-

15,611

Options issued for services in August 2012, vested during 2012,  valued at $0.75/share

-

-

7,137

-

-

-

-

-

7,137

Warrants issued for services in December 2012, vested during 2012,  valued at $0.78/share

-

-

28,237

-

-

-

-

-

28,237

Options extended for services in November 2012, vested during 2012, valued at $0.27/share

-

-

266,710

-

-

-

-

-

266,710

Options extended for services in November 2012, vested during 2012, valued at $0.25/share

-

-

25,420

-

-

-

-

-

25,420

Options extended for services in November 2012, vested during 2012, valued at $0.24/share

-

-

60,283

-

-

-

-

-

60,283

Options extended for services in November 2012, vested during 2012, valued at $0.29/share

-

-

309,049

-

-

-

-

-

309,049

Options extended for services in November 2012, vested during 2012, valued at $0.29/share

-

-

29,375

-

-

-

-

-

29,375

Options extended for services in November 2012, vested during 2012, valued at $0.26/share

-

-

39,270

-

-

-

-

-

39,270

Options extended for services in November 2012, vested during 2012, valued at $0.30/share

-

-

29,529

-

-

-

-

-

29,529

Options extended for services in November 2012, vested during 2012, valued at $0.28/share

-

-

42,195

-

-

-

-

-

42,195

Net loss for the year ending December 31, 2012

-

-

-

-

-

-

-

(4,556,538)

(4,556,538)

BALANCE AT DECEMBER 31, 2012

50,160,758

$

50,161

$

32,042,751

$

-

$

-

$

-

$

(15,827)

$

(28,416,039)

$

3,661,046



See accompanying notes to these financial statements.


-12-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE PERIOD JANUARY 1, 2004 (INCEPTION OF DEVELOPMENT STAGE) TO MARCH 31, 2013 (CONTINUED)

(UNAUDITED)



Subscription

Receivable/

Receivable

Deficit Accumulated

Number of

Common

Paid-in

for Issuance

Deferred

Unrealized Loss

Accumulated

During

Shares

Stock

Capital

of Common Stock

Charges

on Securities

Deficit

Development Stage

Total

BALANCE AT DECEMBER 31, 2012

50,160,758

$

50,161

$

32,042,751

$

-

$

-

$

-

$

(15,827)

$

(28,416,039)

$

3,661,046

Common stock issued to institutional investor, valued at $1.07/share

186,916

187

199,813

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.11/share

3,017

3

3,346

-

-

-

-

-

3,349

Common stock issued to institutional investor, valued at $1.027/share

196,078

196

199,803

-

-

-

-

-

199,999

Common stock issued for additional commitment shares, valued at $1.07/share

3,017

3

3,225

-

-

-

-

-

3,228

Common stock issued to institutional investor, valued at $1.037/share

192,864

193

199,807

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.36/share

3,017

3

4,100

-

-

-

-

-

4,103

Common stock issued to institutional investor, valued at $1.1367/share

175,948

176

199,824

-

-

-

-

-

200,000

Common stock issued for additional commitment shares, valued at $1.35/share

3,017

3

4,070

-

-

-

-

-

4,073

Common stock issued to institutional investor, valued at $1.2533/share

159,579

160

199,841

-

-

-

-

-

200,001

Common stock issued for additional commitment shares, valued at $2.59/share

3,017

3

4,794

-

-

-

-

-

4,797

Exercise of warrants at $1.25/share

12,500

13

15,612

-

-

-

-

-

15,625

Reversal of common stock issuance during 2013 at $0.50/share

(2,000)

(2)

2

-

-

-

-

-

-

Options issued for services in December 2010, vested during 2013, valued at $1.14/share

-

-

20,973

-

-

-

-

-

20,973

Options issued for services in May 2011, vested during 2013, valued at $0.97/share

-

-

11,929

-

-

-

-

-

11,929

Options issued for services in August 2011, vested during 2013, valued at $0.82/share

-

-

10,120

-

-

-

-

-

10,120

Options issued for services in November 2011, vested during 2013, valued at $0.53/share

-

-

6,468

-

-

-

-

-

6,468

Options issued for services in December 2011, vested during 2013, valued at $0.82/share

-

-

12,638

-

-

-

-

-

12,638

Options issued for services in March 2012, vested during 2013, valued at $1.37/share

-

-

29,154

-

-

-

-

-

29,154

Options issued for services in May 2012, vested during 2013, valued at $1.23/share

-

-

113,512

-

-

-

-

-

113,512

Warrants issued for services in May 2012, vested during 2013, valued at $0.97/share

-

-

20,868

-

-

-

-

-

20,868

Options issued for services in June 2012, vested during 2013, valued at $0.73/share

-

-

8,948

-

-

-

-

-

8,948

Options issued for services in August 2012, vested during 2013, valued at $0.74/share

-

-

9,183

-

-

-

-

-

9,183

Options issued for services in August 2012, vested during 2013, valued at $0.75/share

-

-

4,622

-

-

-

-

-

4,622

Warrants issued for services in December 2012, vested during 2013, valued at $0.78/share

-

-

18,066

-

-

-

-

-

18,066

Options issued for services in March 2013, vested during 2013, valued at $1.08/share

-

-

3,443

-

-

-

-

-

3,443

Net loss for three months ending March 31, 2013

-

-

-

-

-

-

-

(922,471)

(922,471)

BALANCE AT MARCH 31, 2013 (UNAUDITED)

51,097,728

$

51,099

$

33,346,912

$

-

$

-

$

-

$

(15,827)

$

(29,338,510)

$

4,043,674






See accompanying notes to these financial statements.


-13-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

STATEMENTS OF CASH FLOW

FOR THE THREE MONTHS ENDING MARCH 31, 2013 AND 2012 AND

FOR THE PERIOD JANUARY 1, 2004 (INCEPTION OF DEVELOPMENT STAGE) TO MARCH 31, 2013

(UNAUDITED)






Cumulative

For the Three

For the Three

Since

Months Ending

Months Ending

Inception

March 31, 2013

March 31, 2012

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss

$

(29,338,510)

$

(922,471)

$

(871,346)

Adjustment to reconcile net loss to net cash

used in operating activities

Amortization of deferred charges

4,392,456

-

-

Amortization of prepaid expenses

75,000

-

-

Warrants issued for services

4,097,707

38,934

73,377

Stock options issued for services

7,020,798

230,990

145,243

Common stock issued for services and fees

1,475,841

19,550

103,443

Purchase right agreement amortization

132,058

-

-

Depreciation and amortization of patents

248,972

26,328

9,548

Realized gain on investments

(3,911)

-

-

Realized gain on disposal of assets

(637)

-

-

(Increase) decrease in assets

Receivables

(30,461)

-

-

Prepaid expenses and other current assets

(75,107)

14,868

(2,392)

Increase (decrease) in liabilities

Accounts payable

258,366

29,067

(42,659)

Accounts payable and accrued expenses- related parties

29,949

20,181

(5,302)

Accrued expenses

42,190

6,400

5,753

Net cash used in operating activities

(11,675,289)

(536,153)

(584,335)

CASH FLOWS FROM INVESTING ACTIVITIES

Cost of intangibles

(533,757)

(10,722)

(26,518)

Proceeds from sale of available for sale securities

203,911

-

-

Proceeds from receipt of note receivable

100,000

-

-

Purchase of available for sale securities

(200,000)

-

-

Purchase of equipment, furniture and leasehold improvements

(538,250)

(86,371)

(13,692)

Net cash used in investing activities

(968,096)

(97,093)

(40,210)

CASH FLOWS FROM FINANCING ACTIVITIES

Issuance of common stock, private placement

7,495,524

-

-

Common stock rescinded, private placement

(200,000)

-

-

Issuance of common stock, exercise of options and warrants

2,037,029

15,625

219,400

Issuance of common stock, exercise of purchase right agreement

45,138

-

-

Issuance of common stock, institutional investor

6,049,999

1,000,000

2,999,998

Repayment of notes payable

(14,970)

-

-

Proceeds from subscription receivable

19,000

-

-

Advances to stockholders

(4,933)

-

-

Proceeds from convertible notes

529,000

-

-

Advances from officers

1,498

-

-

Net cash provided by financing activities

15,957,285

1,015,625

3,219,398

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

3,313,900

382,379

2,594,853

CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD

5,358

2,936,879

359,824

CASH AND CASH EQUIVALENTS - END OF PERIOD

$

3,319,258

$

3,319,258

$

2,954,677




See accompanying notes to these financial statements.


-14-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

STATEMENTS OF CASH FLOW (CONTINUED)

FOR THE THREE MONTHS ENDING MARCH 31, 2013 AND 2012 AND

FOR THE PERIOD JANUARY 1, 2004 (INCEPTION OF DEVELOPMENT STAGE) TO MARCH 31, 2013

(UNAUDITED)




Cumulative

For the Three

For the Three

Since

Months Ending

Months Ending

Inception

March 31, 2013

March 31, 2012

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

CASH PAID DURING THE PERIOD FOR:

Interest

$

23,232

$

-

$

109

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING

AND FINANCING ACTIVITIES

Common stock issued in exchange for deferred charges

$

3,142,400

$

-

$

-

`

Warrants issued in exchange for deferred charges

$

1,581,056

$

-

Common stock issued as settlement for accounts payable

$

74,708

$

-

$

-

Accrued interest contributed as capital

$

35,624

$

-

$

-

Common stock issued in the conversion of notes payable

$

529,000

$

-

$

-

Acquisition of automobile through loan payable

$

24,643

$

-

$

-

Common stock issued upon exercise of a warrant

in exchange for receivable

$

75,000

$

-

$

-

Insurance company pay off of note payable

$

9,673

$

-

$

-

Receivable for issuance of common stock

$

210,001

$

-

$

200,001

Contribution of officer accrued payroll

$

52,129

$

-

$

-

Common stock issued for prepaid expense

$

75,000

$

-

$

-







See accompanying notes to these financial statements.


-15-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2013 AND 2012




NOTE 1- FINANCIAL STATEMENTS


The accompanying unaudited financial statements have been prepared by Lightwave Logic, Inc. (the Company).  These statements include all adjustments (consisting only of its normal recurring adjustments) which management believes necessary for a fair presentation of the statements and have been prepared on a consistent basis using the accounting polices described in the Summary of Accounting Policies included in the 2012 Annual Report.  Certain financial information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to those rules and regulations, although the Company firmly believes that the accompanying disclosures are adequate to make the information presented not misleading.  The financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012, as filed with the Securities and Exchange Commission.  The interim operating results for the three months ending March 31, 2013 may not be indicative of operating results expected for the full year.


Loss Per Share


The Company follows Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 260, “Earnings per Share”, resulting in the presentation of basic and diluted earnings per share.  Because the Company reported a net loss in 2013 and 2012, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.

Comprehensive Income


The Company follows FASB ASC 220.10, “Reporting Comprehensive Income.”  Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income.  Since the Company has no items of other comprehensive income, comprehensive income (loss) is equal to net loss.


Recently Issued Accounting Pronouncements Not Yet Adopted


As of March 31, 2013, there are no recently issued accounting standards not yet adopted which would have a material effect on the Company’s financial statements.


Recently Adopted Accounting Pronouncements


As of March 31, 2013 and for the period then ended, there were no recently adopted accounting pronouncements that had a material effect on the Company’s financial statements.







-16-



LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2013 AND 2012



NOTE 2 – MANAGEMENT’S PLANS

The Company currently has a cash position of approximately $3,600,000.  Based upon the current cash position and expenditures of approximately $250,000 per month and no debt service, management believes the Company has sufficient funds currently to finance its operations through June 2014.  In May 2011, the Company signed an agreement with an institutional investor to sell up to $20 million of common stock. Under the agreement subject to certain conditions and at the Company's sole discretion, the institutional investor has committed to invest up to $20 million in the Company's common stock over a 30-month period with the remaining available amount of $13,150,001.  The Company filed a registration statement with the U.S. Securities and Exchange Commission covering the resale of the shares that may be issued to the institutional investor.  The institutional investor is obligated to make purchases as the Company directs in accordance with the agreement that may be terminated by the Company at any time, without cost or penalty.  Sales of shares will be made in specified amounts and at prices that are based upon the market prices of the Company's common stock.  Additional funding may also be provided by the exercise of outstanding warrants of up to approximately $1,500,000 through September 2013.  With additional capital raised, the Company expects to achieve a level of revenues attractive enough to fulfill its development activities and achieve a level of revenue adequate to support the Company’s business model.  The Company continues to develop and test its next generation Electro-Optic and third-order material platform to support and cultivate potential customers, strategic partners and develop photonic devices.  Management believes the Company’s initial revenue stream will be in prototype devices, application and non-recurring engineering charges, and material charges for specialty non-linear application prior to moving into full commercialization and production.


NOTE 3 – PROPERTY AND EQUIPMENT


Property and equipment consists of the following:


March 31, 2013

December 31, 2012

Office equipment

$

17,316

$

12,741

Lab equipment

462,499

388,521

Furniture

4,061

4,061

Leasehold Improvements

35,952

28,134

519,828

433,457

Less: Accumulated depreciation

155,076

132,463

$

364,752

$

300,994



Depreciation expense for the three months ending March 31, 2013 and 2012 was $22,613 and $6,736.





-17-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2013 AND 2012




NOTE 4 – INTANGIBLE ASSETS


This represents legal fees and patent fees associated with the prosecution of patent applications.  The Company has recorded amortization expenses on the Spacer and Chromophore patents granted by the United States Patent and Trademark Office in February 2011, April 2011 and September 2012, which are amortized over its legal life of 20 years and Chromophore patent granted by the Australian Patent Office in November 2012 which is amortized over its legal life of 20 years.  Certain patent applications are abandoned by the Company when the claims are covered by patents already granted to the Company.  Patent applications abandoned have been written off at full capitalized cost.  No amortization expense has been recorded on the remaining patent applications since patents have yet to be granted.  Once the patents are granted, the cost of the patents will be amortized over their legal lives, which is generally 20 years.


Patents consists of the following:


March 31, 2013

December 31, 2012

Patents

$

520,082

$

509,360

Less: Accumulated amortization

24,549

20,834

$

495,533

$

488,526



Amortization expense for the three months ending March 31, 2013 and 2012 was $3,715 and $2,811.  Expense for abandoned patents for claims covered by patents already granted to the Company are recorded in research and development expenses and for the three months ending March 31, 2013 and 2012 were $0 and $0.


NOTE 5 – INCOME TAXES


There is no income tax benefit for the losses for the three months ended March 31, 2013 and 2012 since management has determined that the realization of the net deferred tax asset is not assured and has created a valuation allowance for the entire amount of such benefits.


The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations.  As of January 1, 2013, the Company had no unrecognized tax benefits, or any tax related interest of penalties.  There were no changes in the Company’s unrecognized tax benefits during the period ended March 31, 2013.  The Company did not recognize any interest or penalties during 2013 related to unrecognized tax benefits.  With few exceptions, the U.S. and state income tax returns filed for the tax years ending on December 31, 2009 and thereafter are subject to examination by the relevant taxing authorities.







-18-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2013 AND 2012




NOTE 6 – STOCKHOLDERS’ EQUITY


Preferred Stock

Pursuant to our Company’s Articles of Incorporation, our board of directors is empowered, without stockholder approval, to issue series of preferred stock with any designations, rights and preferences as they may from time to time determine.  The rights and preferences of this preferred stock may be superior to the rights and preferences of our common stock; consequently, preferred stock, if issued could have dividend, liquidation, conversion, voting or other rights that could adversely affect the voting power or other rights of the common stock.  Additionally, preferred stock, if issued, could be utilized, under special circumstances, as a method of discouraging, delaying or preventing a change in control of our business or a takeover from a third party.


Common Stock and Warrants


The stockholders’ deficit at January 1, 2004 has been retroactively restated for the equivalent number of shares received in the reverse acquisition at July 14, 2004 (Note 1) after giving effect to the difference in par value with the offset to additional paid-in-capital.


During April 2008, the Company issued a warrant to purchase 600,000 shares of common stock at a purchase price of $0.73 per share for consulting services rendered.  The warrant was valued at $976,193, fair value, using the Black-Scholes Option Pricing Formula, vesting immediately.  For the year ended December 31, 2008, the Company recognized $976,193 in consulting expense.  During January 2013, the warrant agreement was amended from 600,000 warrants to 400,000 shares at an exercise price of $0.73 expiring October 2013 and 200,000 shares were rescinded.  The modification did not result in the recognition of any additional expense.  The warrant to purchase 400,000 shares of common stock is still outstanding as of March 31, 2013.


During 2010, the Company issued 1,500,000 shares of common stock and warrants to purchase 375,000 shares of common stock with 156,250 warrants expiring September 2011 and 218,750 warrants expiring December 2011 for proceeds of $1,500,000 in accordance to a private placement memorandum as amended on September 14, 2010.  Pursuant to the terms of the offerings, up to 30 units were offered at the purchase price of $50,000 per unit, with each unit comprised of 50,000 shares and a warrant to purchase 12,500 shares of common stock at $1.25 per share.  During September 2011, all warrants were extended one year expiring September 2012 and December 2012.   In January 2012, some warrants were exercised to purchase 40,000 shares of common stock for proceeds of $50,000.  During August 2012, all remaining warrants were extended six months expiring March 2013 and June 2013.  During March 2013, 335,000 warrants were extended three months expiring June 2013 and September 2013.  The extension did not result in the recognition of any additional expense.  In March 2013, a warrant was exercised to purchase 12,500 shares of common stock for proceeds of $15,625.  The remaining warrants to purchase 322,500 shares of common stock at $1.25 per share are still outstanding as of March 31, 2013.




-19-




LIGHTWAVE LOGIC, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2013 AND 2012




NOTE 6 – STOCKHOLDERS’ EQUITY (CONTINUED)


Common Stock and Warrants (Continued)


In May 2011, the Company has signed an agreement with an institutional investor to sell up to $20 million of common stock. Under the agreement subject to certain conditions and at the Company's sole discretion, the institutional investor has committed to invest up to $20 million in the Company's common stock over a 30-month period. The Company filed a registration statement with the U.S. Securities and Exchange Commission covering the resale of the shares that may be issued to the institutional investor.  The institutional investor is obligated to make purchases as the Company directs in accordance with the agreement, which may be terminated by the Company at any time, without cost or penalty. Sales of shares will be made in specified amounts and at prices that are based upon the market prices of the Company's common stock immediately preceding the sales to the institutional investor.  The Company has issued 150,830 shares of common stock to the institutional investor as an initial commitment fee valued at $162,896, fair value and 301,659 shares of common stock are reserved for additional commitment fees to the institutional investor in accordance with the terms of the agreement.  During June, 2011 through March, 2013, the institutional investor purchased 4,635,670 shares of common stock for proceeds of $6,049,997.  The Company issued 91,262 shares of common stock as additional commitment fee, valued at $153,833, fair value, leaving 210,397 in reserve for additional commitment fees.  For the three month ending March 31, 2013, the institutional investor purchased 911,385 shares of common stock for proceeds of $1,000,000 and the Company issued shares 15,085 of common stock as additional commitment fee, valued at $19,550, fair value.


In March 2013, the board of directors approved a grant to a new employee of a option to purchase up to 75,000 shares of common stock at a purchase price of $1.16 per share. Using the Black-Scholes Option Pricing Formula, the option was valued at $81,076, fair value. The option expires in 10 years with 9,375 vesting quarterly from date of grant.  The option is expensed over the vesting terms.  For the three month ending March 31, 2013, the Company recognized $3,443 of expense.  As of March 31, 2013, option to purchase 75,000 shares of common stock are still outstanding.


NOTE 7 – STOCK BASED COMPENSATION


The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award, with the following assumptions for 2013: no dividend yield, expected volatility, based on the Company’s historical volatility, 113%, risk-free interest rate 1.86% and expected option life of ten years in 2013.


As of March 31, 2013, there was $640,399 of unrecognized compensation expense related to non-vested market-based share awards that is expected to be recognized through June 2015.


The following tables summarize all stock option and warrant activity of the Company during the three months ended March 31, 2013:







-23-






NOTE 7 – STOCK BASED COMPENSATION (CONTINUED)


Non-Qualified Stock Options and Warrants Outstanding and Exercisable

Number of

Exercise

Weighted Average

Shares

Price

Exercise Price

Outstanding, December 31, 2012

8,773,500

$0.25 - $1.75

$

1.13

Granted

75,000

$              1.16

$

1.16

Expired

Forfeited

(200,000)

$              0.73

$

0.73

Exercised

(12,500)

$              1.25

$

1.25

Outstanding, March 31, 2013

8,636,000

$0.25 - $1.75

$

1.14

Exercisable, March 31, 2013

7,742,612

$0.25 - $1.75

$

1.16



Non-Qualified Stock Options and Warrants Outstanding

Number Outstanding

Weighted Average

Weighted Average

Range of

Currently Exercisable

Remaining

Exercise Price of Options and

Exercise Prices

at March 31, 2013

Contractual Life

Warrants Currently Exercisable

$0.25 - $1.75

7,742,612

2.62 Years

$

1.16


NOTE 8 – RELATED PARTY


At March 31, 2013 the Company has accrued salaries to officers and two beneficial owners of $46,538.


NOTE 9 – SUBSEQUENT EVENTS


During April and May 2013, the institutional investor under the Company’s May 2011 agreement purchased 717,001 shares of common stock for proceeds of $800,001.  The Company issued 12,068 shares of common stock as additional commitment fee, valued at $14,723, fair value.


In May 2013, a new employee was granted an option to purchase up to 10,000 shares of common stock at an exercise price of $1.03 per share.  Using the Black-Scholes Option Pricing Formula, the options were valued at $9,574, fair value.  These options expire in 10 years and 1,250 shares vest quarterly commencing August 1, 2013.  The option will be expensed over the vesting terms.




-24-






Forward-Looking Statements


This report on Form 10-Q contains forward-looking statements. Forward-looking statements involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “we believe,” “we intend,” “may,” “should,” “will,” “could” and similar expressions denoting uncertainty or an action that may, will or is expected to occur in the future. These statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from any future results, performances or achievements expressed or implied by the forward-looking statements. You should not place undue reliance on these forward-looking statements.


Factors that that are known to us that could cause a different result than projected by the forward-looking statement, include, but are not limited to: lack of available funding; general economic and business conditions; competition from third parties; intellectual property rights of third parties; regulatory constraints; changes in technology and methods of marketing; delays in completing various engineering and manufacturing programs; changes in customer order patterns; changes in product mix; success in technological advances and delivering technological innovations; shortages in components; production delays due to performance quality issues with outsourced components; those events and factors described by us in Item 1.A “Risk Factors” in our most recent Annual Report on Form 10-K; other risks to which our Company is subject; other factors beyond the Company's control.


Any forward-looking statement made by us in this report on Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.


Item 2

Management's Discussion and Analysis of Financial Condition and Results of Operations


The following management’s discussion and analysis of financial condition and results of operations provides information that management believes is relevant to an assessment and understanding of our plans and financial condition. The following selected financial information is derived from our historical financial statements and should be read in conjunction with such financial statements and notes thereto set forth elsewhere herein and the "Forward-Looking Statements" explanation included herein.


Overview


Lightwave Logic, Inc. (then known as Eastern Idaho Internet Service, Inc.) was organized under the laws of the State of Nevada in 1997, where we engaged in the business of marketing Internet services until June 30, 1998 when our operations were discontinued.  We were then inactive until we acquired PSI-TEC Corporation as our wholly owned subsidiary on July 14,



-25-






2004, at which time our name was changed to PSI-TEC Holdings, Inc.  On October 20, 2006, we completed a parent-subsidiary merger with PSI-TEC Corporation whereby we were the surviving corporation of the merger, and our name was changed to Third-Order Nanotechnologies, Inc. On March 10, 2008, we changed our name to Lightwave Logic, Inc. to better suit our strategic business plan and to facilitate stockholder recognition of our Company and our business. Unless the context otherwise requires, all references to the “ Company ,” “ we ,” “ our ” or “ us ” and other similar terms means Lightwave Logic, Inc., a Nevada corporation.


We are a development stage, organic nonlinear materials and electro-optical device company. Our primary area of expertise is the chemical synthesis of chromophore dyes used in the development of organic Application Specific Electro-Optic Polymers (ASEOP) and Organic Non-Linear All-Optical Polymers (NLAOP) that have high electro-optic and optical activity. Both types of materials are thermally and photo-chemically stable, which we believe could have utility across a broad range of applications in devices that address markets like, telecommunication, data communications, high-speed computing and photovoltaic cells.  Secondarily, the company is developing proprietary electro-optical and all-optical devices utilizing the advanced capabilities of our materials for the application in the fields mentioned above.


In order to transmit digital information at extremely high-speeds (wide bandwidth) over the Internet, it is necessary to convert the electrical signals produced by a computer into optical signals for transmission over long-distance fiber-optic cable.   Molecularly engineered materials known as electro-optic polymers when designed into optical devices perform the actual conversion of an electrical signal to an optical signal.


We are currently developing electro-optic polymers that promise performance many times faster than any technology currently available and that have unprecedented thermal stability. High-performance electro-optic materials produced by our Company have demonstrated stability as high as 350 degrees Celsius.  Stability above 250 degrees Celsius is necessary for vertical integration into many semi-conductor production lines. In December 2011 one of our non-linear optical polymers, Perkinamine Indigo TM demonstrated an unusually high electro-optical effect of greater than 250 picometers per volt with excellent thermal and photo stability.  Independent research laboratories at Photon-X and The University of Colorado confirmed these characteristics. We continue our development program on Perkinamine Indigo TM to better understand the properties that gave us the results reported in December 2011.


Our non-linear all optical polymers have demonstrated resonantly enhanced Third-order properties about 2,630 times larger than fused silica, which means that they are very photo-optically active in the absence of an RF layer.  In this way they differ from our electro-optical polymers and are considered more advanced next-generation materials.


Our revenue model relies substantially on the assumption that we will be able to successfully develop non-linear polymer materials and photonic device products, which will use non-linear all-optical and electro-optic polymers for applications within the industries described below. When appropriate, we intend to create specific materials for each of these applications and use our proprietary knowledge base to continue to enhance its discoveries.



-26-






·

telecommunications/data communications

·

backplane optical interconnects

·

cloud computing and data centers

·

photovoltaic cells

·

medical applications

·

satellite reconnaissance

·

navigation systems

·

radar applications

·

optical filters

·

special light modulators

·

all-optical transistors

·

entertainment

To be successful, we must, among other things:

·

Develop and maintain collaborative relationships with strategic partners;

·

Continue to expand our research and development efforts for our products;

·

Develop and continue to improve on our manufacturing processes and maintain stringent quality controls;

·

Produce commercial quantities of our products at commercially acceptable prices;

·

Rapidly respond to technological advancements;

·

Attract, retain and motivate qualified personnel; and

·

Obtain and retain effective intellectual property protection for our products and technology.

We believe that Moore's Law (a principle which states the number of transistors on a silicon chip doubles approximately every eighteen months) will create markets for our high-performance electro-optic materials and photonic device products.

Plan of Operation

Since inception, we have been engaged primarily in the research and development of our polymer materials technologies and potential photonic device products. We are devoting significant resources to engineer next-generation electro-optic polymers for future applications to be utilized by electro-optic device manufacturers, such as telecommunications component and systems manufacturers, networking and switching suppliers, semiconductor companies, aerospace companies, government agencies and internal device development. We expect to continue to develop products that we intend to introduce to these rapidly changing markets and to seek to identify new markets. We expect to continue to make significant operating and capital expenditures for research and development activities.

As we move from a development stage company to a product supplier, we expect that our financial condition and results of operations will undergo substantial change. In particular, we expect to record both revenue and expense from product sales, to incur increased costs for sales and marketing and to increase general and administrative expense. Accordingly, the financial condition and results of operations reflected in our historical financial statements are not expected to be indicative of our future financial condition and results of operations.



-27-






On September 25, 2006 we obtained independent laboratory results that confirmed the thermal stability of our Perkinamine TM electro-optic materials. Thermal stability as high as 350 degrees Celsius was confirmed, significantly exceeding many other then commercially available high performance electro-optic materials, such as CLD-1 that exhibits thermal degradation in the range of 250 degrees Celsius to 275 degrees Celsius. This high temperature stability of our materials eliminates a major obstacle to vertical integration of electro-optic polymers into standard microelectronic manufacturing processes (e.g. wave/vapor-phase soldering) where thermal stability of at least 300 degrees Celsius is required. In independent laboratory tests, ten-percent material degradation, a common evaluation of overall thermal stability, did not occur until our Perkinamine TM materials base was exposed to temperatures as high as 350 degrees Celsius, as determined by Thermo-Gravimetric Analysis (TGA). The test results supported our Company's progress to introduce our materials into commercial applications such as optical interconnections, high-speed telecom and datacom modulators, and military/aerospace components.


On September 26, 2006, we were awarded the 2006 Electro-Optic Materials Technology Innovation of the Year Award by Frost & Sullivan.  Frost & Sullivan's Technology Innovation of the Year Award is bestowed upon candidates whose original research has resulted in innovations that have, or are expected to bring, significant contributions to multiple industries in terms of adoption, change, and competitive posture. This award recognizes the quality and depth of our Company's research and development program as well as the vision and risk-taking that enabled us to undertake such an endeavor.


In July 2007, our Company developed an innovative process to integrate our unique architecture into our anticipated commercial devices, whereby dendritic spacer systems are attached to its core chromophore. In the event we are successful in developing a commercially viable product, we believe these dendrimers will reduce the cost of manufacturing materials and reduce the cost and complexity of tailoring the material to specific customer requirements.


In March 2008, we commenced production of our first prototype photonic chip, which we delivered to Photon-X, LLC to fabricate a prototype polymer optical modulator and measure its technical properties. In June 2009 we released test results conducted by Dr. C.C. Teng that re-confirmed our previous test results.


In August 2009, Photon-X, LLC commenced a compatibility study, process sequences, and fabricated wafers/chips containing arrays of phase modulators. The first one hundred plus modulators (bench top devices) were completed at the end of October 2009, and were successfully characterized for insertion loss, Vpi, modulation dynamic range and initial frequency response in March 2010. The multi-step manufacturing process we utilized to fabricate our modulators involved exposing our proprietary Perkinamine TM materials to extreme conditions that is typically found in standard commercial manufacturing settings. Our step-by-step analysis throughout the fabrication process demonstrated to us that our Perkinamine TM materials could successfully withstand each step of the fabrication process without damage.




-28-






In August 2009, we retained Perdix, Inc. in Boulder, Colorado to help us identify and build prototype products for high growth potential target markets in fiber optic telecommunications systems. During October 2009, we initiated the development and production of our prototype amplitude modulator, which can ultimately be assembled into 1- and 2- dimensional arrays that are useful for optical computing applications, such as encryption and pattern recognition. We expected our initial prototype amplitude modulator to be completed by the end of the second quarter 2010. We continued to work on this device throughout 2010 and discovered its design had limitations so we terminated the program to take a different design approach. We embarked on the new design approach in 2011 with another partner, Boulder Nonlinear Systems (BNS). A feasibility study with the new design partner was started in late 2011. This research and development program continued through 2012 into the first half of 2013.

In December 2009, we filed our sixth patent application. The provisional application covers stable free radical chromophores for use in Non-Linear optical applications. The new polymeric electro-optic material has enormous potential in spatial light modulation and all optical signal processing (light switching light).

In March 2010, we successfully concluded the electrical and optical performance testing stage of our proof of principle prototype phase modulator and began application engineering of our technology in customer design environments.  The Company is working directly with interested large system suppliers to attempt to engineer specific individual electro-optic materials in support of their proprietary device designs, which would be implemented in next generation products.

In October of 2010, we completed the concept stage of a novel design for an advanced optical computing application and moved forward into the design stage with Celestech, Inc. of Chantilly, Virginia.  This application is presently on hold while Celestech continues to engage its customer on its schedule. Additionally, we are working on three other applications with Celestech, two of which are in white paper design stage. Development of these applications continued through 2012 and into 2013. If these projects continue to move forward, they will incorporate one or more of our Company’s advanced electro-optical polymer materials.

In October of 2010, we announced the results of testing performed by Lehigh University that demonstrated the Third-order non-linear properties of our proprietary molecules in the Perkinamine NR TM chromophore class.  Lehigh University determined that the material was 100 times stronger than the highest off-resonance small molecule currently known.  They also determined that it was 2,600 times more powerful than fused silica and demonstrated extremely fast (less than 1 picosecond) photo-induced non-linear response that would be capable of modulation at a rate of 1 THz (terahertz). Additional testing at Lehigh University of the Company’s other Perkinamine class of materials demonstrated Third-order non-linear properties, which may have utility in all optical switches.

In February and April 2011, respectively, the United States Patent Office granted our Company two patents:  US Patent No. 7,894,695 covering our Tricyclic Spacer System for Non-Linear Optical Devices and US Patent No. 7,919,619 for Heterocyclical Chromophore Architectures directed to our Perkinamine TM chromophores.  These composition of matter patents taken together protect the core of our electro-optical materials portfolio.



-29-






In March 2011, we entered into a research and development agreement with the City University of New York’s (“CUNY”) Laboratory for Nano Micro Photonics (LaNMP) to develop Third-order non-linear devices. The combination of LaNMP’s device capabilities together with our materials expertise should accelerate the development of all-optical devices. The agreement ran through the end of 2011. The goal of the project was to fabricate and test slot waveguides embedded with two types of nonlinear optical polymers obtained from our Company. These two polymers were Perkinamine TM and Perkinamine NR TM . In CUNY’s final report it showed they successfully demonstrated that the Perkinamine and Perkinamine NR survived their 170 o C processing temperature without degradation. According to their report, they were successful in one processing run wherein they showed the possibility to realize waveguides with very smooth sidewalls. Reflectivity measurements carried out under optical pumping showed phase shift in the Perkinamine TM material. We are continuing research in this area with the University of Colorado, Boulder.


In March 2011 the City University of New York’s Laboratory for Nano Micro Photonics (LaNMP) fabricated our first-ever all optical waveguides using Perkinamine TM and Perkinamine NR TM chromophores.  It is anticipated that LaNMP could use this device architecture to develop various all-optical devices including an all-optical transistor. This effort, starting with an all-optical switch, is being continued at the University of Colorado, Boulder through an agreement entered into in January 2013.


In December 2011, we announced the discovery of a new material named Perkinamine Indigo TM .  We believe this represents a major advancement in the field of organic nonlinear optical materials.  The material demonstrated an unusually high electro-optical effect of greater than 250 picometers per volt with excellent thermal and photo stability.  Independent research laboratories at Photon-X and The University of Colorado confirmed these characteristics. We do, however, have to do a complete characterization of these materials to fully understand what material properties are causing these results before any of our partners will move forward with this material. The major microelectronics company we are working with will be characterizing the material at their location using their proprietary devices while we continue our work with the University of Colorado, Boulder. In order to further characterize our Perkinamine class of materials, including Perkinamine Indigo TM , the Company has developed Mach-Zehnder interferometry and standard Teng-Man test set-ups in its own facilities. The Company’s optical lab is starting to test materials.


In June 2012 we opened a new internal research laboratory facility in Newark, Delaware in the Delaware Technology Park, near the University of Delaware. This new lab facility enables us to synthesize and test our materials in the same facility and will help us accelerate our development efforts. It is equipped with state of the art equipment necessary to expand our ability to conduct synthetic chemistry in much more tightly controlled conditions. Additionally, we have equipped a separate advanced optical laboratory at the same location where the necessary testing of material candidates will be performed as they emerge from our new synthesis laboratory.





-30-






In July 2012 we entered into an agreement with The University of Colorado, Boulder to conduct analytical testing and to carry out studies that will give a better understanding of the properties of a new class of composite organic electro-optic materials. This class of materials is our Perkinamine Indigo TM . The processing and measurements are to be carried out primarily at the Guided Wave Optics Laboratory (GWOL). The work is being done in close collaboration with Company personnel.


In September 2012 the United States Patent Office granted our Company U.S. Patent No. 8,269,004, entitled Heterocyclical Anti-Aromatic Chromophore Architectures.  This patent protects the unique molecular structures that give our chromophores the thermal stability necessary to withstand CMOS processing temperatures without compromising electro-optical effects.


In November 2012 Australia granted our Company Australian Patent No. AU2005302506 entitled Heterocyclical Chromophore Architectures.  This patent protects the unique molecular structures that give our chromophores the thermal stability necessary to withstand CMOS processing temperatures without compromising electro-optical effects.


In February 2013 we delivered to a potential microelectronics customer prototype devices that were coated with our advanced organic nonlinear electro-optical polymer, Perkinamine Indigo TM . Tests conducted by the University of Colorado, Boulder on coupons coated with the material demonstrated consistent R 33 measurements from 100-125 picometers per volt, which exceeded the potential microelectronics customer's stated requirements.


In March 2013 we entered into a product development contractor agreement with EM Photonics (EMP) of Newark, Delaware to fabricate and test waveguides and phase modulators during an initial development phase using existing EMP polymer modulator design and processes. The phase modulator will utilize our advanced organic nonlinear electro-optical polymer, Perkinamine Indigo TM material, which we provided to EMP. This effort is predicated on the compatibility of EMP’s processes with our EO materials. EMP will produce demonstration organic EO polymer waveguides and phase modulators and assess device performance. We anticipate that this product development contract could lead us into a collaboration with EMP that would enable us to develop an advanced telecom modulator utilizing an organic electro-optic modulator with performance parameters and data rates that are significantly advanced over legacy modulators. We have multi-paths in our advanced telecom modulator development, of which EMP is only one of those paths.

In April 2013 our potential microelectronics customer informed us that their preliminary testing results on the prototype devices coated with Perkinamine Indigo™ that we delivered to them in February 2013 demonstrated several of the key performance parameters that they desired. There are still additional tests that need to be completed.  We are working with our potential customer utilizing our Perkinamine Indigo™ chromophore in a number of host polymers and will  evaluate these polymers  for a specific performance attributes for their application.




-31-






In April 2013 Japan granted our Company Japanese Patent No. 5241234 entitled Heterocyclical Chromophore Architectures.  This patent protects the unique molecular structures that give our chromophores the thermal stability necessary to withstand CMOS processing temperatures without compromising electro-optical effects.


We ultimately intend to use our next-generation non-linear all-optical and electro-optic polymers for future applications vital to the following industries. We expect to create specific materials for each of these applications as appropriate:


·

telecommunications/data communications

·

backplane optical interconnects

·

cloud computing and data centers

·

photovoltaic cells

·

medical applications

·

satellite reconnaissance

·

navigation systems

·

radar applications

·

optical filters

·

special light modulators

·

all-optical transistors and

·

entertainment


In an effort to maximize our future revenue stream from our non-linear all-optical and electro-optic polymer products, our business model anticipates that our revenue stream will be derived from one or some combination of the following: (i) technology licensing for specific product applications; (ii) joint venture relationships with significant industry leaders; or (iii) the production and direct sale of our own electro-optic device components. Our objective is to be a leading provider of proprietary technology and know-how in the photonic device markets. In order to meet this objective, subject to successful testing of our technology and having available financial resources, we intend to:


·

Develop non-linear all-optical and electro-optic polymers and photonic devices;

·

Continue to develop proprietary intellectual property;

·

Streamline our product development process;

·

Develop a comprehensive marketing plan;

·

Maintain/develop strategic relationships with government agencies, private firms, and academic institutions; and

·

Continue to attract and retain high level science and technology personnel to our Company.


Our Proprietary Products in Development


As part of a two-pronged marketing strategy, our Company is developing several devices, which are in various stages of development that utilize our organic nonlinear optical materials.




-32-






They include:


Telecommunications Modulator


We have recently begun a second-generation design of a unique telecommunications modulator incorporating our newly developed material Perkinamine TM Indigo.  We intend to have a working bench-top prototype sometime during 2013 followed by fully packaged modulators for commercial marketing. We anticipate this modulator will be able to exceed the performance of existing legacy modulators by an order of magnitude, and will allow for improvements in the form of reduced power consumption and reduced device cost.


Spatial Light Modulator


We have a development program to develop a Spatial Light Modulator with an outside manufacturer, Boulder Nonlinear Systems (BNS) utilizing certain Perkinamine TM chromophores.  A spatial modulator is a form of optical computer that can perform various advanced tasks, such as object and facial recognition, by using advanced mathematical calculations known as Fourier Transforms. Our organic nonlinear optical materials can potentially produce update rates of more than a million times per second, which is a significant improvement in processing speed over existing Liquid Crystal Display technology that updates at only 30 times per second.


Optical Filter


We are in preliminary design and fabrication phases of development of an optical filter using our proprietary Perkinamine TM and Perkinamine NR TM materials within a SiNx photonics platform.  Initial work has been done in collaboration with City University of New York, but limitations in their process capabilities have led us to seek alternate fabrication facilities, which are underway at this time.


All-Optical Switch


An all-optical switch is one that enables signals in optical fibers or networks to be selectively switched from one fiber or circuit to another.  Many device designs have been developed and commercialized in today’s telecom networks to effect optical switching by using mechanical or electrical control elements to accomplish the switching event.  Future networks will require all-optical switches that can be more rapidly activated with a low energy and short duration optical (light) control pulse. We are in early development of an all-optical switch in collaboration with the University of Colorado, Boulder and a potential customer.


Multi-Channel Optical Modem


We are in early feasibility study of a multi-wavelength optical modem that will enable an order of magnitude increase in Internet capacity over legacy fiber.




-33-






Additionally, we must create an infrastructure, including operational and financial systems, and related internal controls, and recruit qualified personnel. Failure to do so could adversely affect our ability to support our operations.


We have incurred substantial net losses since inception. We have satisfied our capital requirements since inception primarily through the issuance and sale of our common stock. During 2004 we raised approximately $529,000 from the issuance of convertible promissory notes, of which $30,000 was converted into common stock of the Company during 2004 and the remaining $499,000 converted in 2005. Also, during 2005, we raised an aggregate of $1,000,000 from the private sale of our common stock. During 2006 we raised approximately $425,000 from the private sale of our common stock, of which $200,000 was rescinded during 2007. During 2007 we raised approximately $2,301,524 from the private sale of our common stock. During 2008 we raised approximately $414,000 from the private sale of our common stock and $375,270 from the exercise of outstanding warrants. Through June 30, 2009, we raised approximately $855,000 from the private sale of our common stock. We also issued shares of our common stock and warrants to purchase shares of our common stock in exchange for services rendered to our Company, including professional services.  During October 2009 we obtained proceeds of $455,000 from the exercise of outstanding warrants. During 2010 we raised $1,500,000 from the private sale of our common stock and $539,000 from the exercise of outstanding options and warrants. We also issued shares of our common stock and warrants to purchase shares of our common stock in exchange for services rendered to our Company.


During 2011 we raised $1,000,000 from the private sale of our common stock and warrants to purchase our common stock. We also issued shares of our common stock and warrants to purchase shares of our common stock in exchange for services rendered to our Company. Additionally, in May 2011, we signed an agreement with Lincoln Park Capital Fund, LLC (“Lincoln Park”) to sell up to $20 million of common stock. Under the agreement subject to certain conditions and at our sole discretion, Lincoln Park has committed to invest up to $20 million in our common stock over a 30-month period. We filed a registration statement with the U.S. Securities and Exchange Commission covering the resale of the shares that may be issued to Lincoln Park.  Lincoln Park is obligated to make purchases as we direct in accordance with the agreement, which may be terminated by us at any time, without cost or penalty. Sales of shares are made in specified amounts and at prices that are based upon the market prices of our common stock immediately preceding the sales to Lincoln Park.


During 2011 Lincoln Park purchased 185,185 shares of common stock for proceeds of $200,000. During 2012 Lincoln Park purchased 3,539,100 shares of common stock for proceeds of $4,849,999.  Also, during 2012, we raised $447,700 from the exercise of options and warrants. From January 1, 2013 to March 31, 2013, Lincoln Park purchased 911,385 shares of common stock for proceeds of $1,000,000.  During April and early May 2013, Lincoln Park purchased 717,001 shares of common stock for proceeds of $800,001.



-34-






Results of Operations


Results of Operations


Comparison of three months ended March 31, 2013 to three months ended March 31, 2012


Revenues


As a development stage company, we had no revenues during the three months ended March 31, 2013 and 2012.  The Company is in various stages of material evaluation and product development with potential customers and expects the next revenue stream to be in prototype devices, application and non-recurring engineering charges and sale of electro-optic polymer materials prior to moving into production.


Operating Expenses


Our operating expenses were $903,000 and $769,599 for the three months ended March 31, 2013 and 2012, respectively, for an increase of $133,401. This increase in operating expenses was due primarily to increases in salaries and wages, laboratory lease rent, general and administrative non-cash stock option and warrant amortization, depreciation, insurance expense and legal expenses offset by decreases in laboratory electro-optic device prototype, development and outsourced testing expenses, consulting expenses and research and development non-cash stock option and warrant amortization.


Included in our operating expenses for the three months ended March 31, 2013 was $455,382 for research and development expenses compared to $472,409 for the three months ended March 31, 2012, for a decrease of $17,027.  This is primarily due to decreases in outsourced testing expenses, consulting expenses and non-cash stock option and warrant amortization offset by increases in salaries and wages, laboratory rent and depreciation.


Research and development expenses currently consist primarily of compensation for employees engaged in internal research, product and application development activities; laboratory operations, outsourced material testing and prototype electro-optic device design, development and processing work; customer testing; fees; costs; and related operating expenses.


We expect to continue to incur substantial research and development expense to develop and commercialize our electro-optic material platform. These expenses will increase as a result of accelerated development effort to support commercialization of our non-linear optical polymer materials technology; outsourcing work to build device prototypes; expanding and equipping in-house laboratories; hiring additional technical and support personnel; engaging a senior technical advisor; pursuing other potential busin ess opportunities and collaborations; customer testing and evaluation; and incurring related operating expenses.





-35-






Wages and salaries increased $36,519 from $135,815 for the three months ended March 31, 2012 to $172,334 for the three months ended March 31, 2013 primarily due to additional employees hired to perform in-house material testing and material and device development in the Company’s new lab facility. Accordingly, laboratory electro-optic device prototype, development and outsourced testing expenses decreased $36,660 from $86,379 for the three months ended March 31, 2012 to $49,719 for the three months ended March 31, 2013.  Also consulting expenses decreased $19,437 from $27,602 for the three months ended March 31, 2012 to $8,165 for the year ended March 31, 2013.


Non-cash stock option amortization decreased $18,640 from $148,925 for the three months ended March 31, 2012 to $130,285 for the three months ended March 31, 2013.


During the second half of 2012, the Company leased additional laboratory space and rent expense increased accordingly $16,838 from $2,661 for the three months ended March 31, 2012 to $19,499 for the three months ended March 31, 2013.  Depreciation expense increased $15,905 from $6,445 for the three months ended March 31, 2012 to $22,350 for the three months ended March 31, 2013 primarily due to the additional equipment purchased for the new lab facility.


General and administrative expense consists primarily of compensation and support costs for management staff, and for other general and administrative costs, including executive, sales and marketing, investor relations, accounting and finance, legal, consulting and other operating expenses.


General and administrative expenses increased $150,428 to $447,618 for the three months ended March 31, 2013 compared to $297,190 for the three months ended March 31, 2012.  The increase is due primarily to increases in wages and salaries, non-cash amortization of options and warrants, insurance expense and legal expense.


In May 2012, the board of directors appointed its current Non-Executive Chairman of the Board of Directors as its Executive Chairman of the Board of Directors and Chief Executive Officer.  As a result, wages and salaries increased $41,072 from $87,505 for the three months ended March 31, 2012 to $128,577 for the three months ended March 31, 2013.


Non-cash stock option amortization increased $76,799 from $62,840 for the three months ended March 31, 2012 to $139,639 for the three months ended March 31, 2013.


Insurance increased $25,079 from $21,855 for the three months ended March 31, 2012 to $46,934 for the three months ended March 31, 2013.


Legal fees increased $9,072 to $37,834 for the three months ended March 31, 2013 compared to $28,762 for the three months ended March 31, 2012.


We expect general and administrative expense to increase in future periods as we increase the level of corporate and administrative activity, including increases associated with our operation as a public company; and significantly increase expenditures related to the future production and sales of our products.



-36-






Other Income (Expense)


Other income (expense) decreased $82,276 to ($19,471) for the three months ended March 31, 2013 from ($101,747) for the three months ended March 31, 2012, relating primarily to the commitment fee associated with the resale of shares to an institutional investor during the corresponding three-month period.


Net Loss


Net loss was $922,471 and $871,346 for the three months ended March 31, 2013 and 2012, respectively, for an increase of $51,125, primarily due to increases in salaries and wages, laboratory lease rent, general and administrative non-cash stock option and warrant amortization, depreciation, insurance expense and legal expenses offset by decreases in commitment fee to institutional investor, outsourced testing expenses, consulting expenses and research and development non-cash stock option and warrant  amortization.


Significant Accounting Policies


Our discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates based upon historical experience and various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our actual results may differ materially from these estimates.

We believe our significant accounting policies affect our more significant estimates and judgments used in the preparation of our financial statements.  Our Annual Report on Form 10-K for the year ended December 31, 2012 contains a discussion of these significant accounting policies. There have been no significant changes in our significant accounting policies since December 31, 2012.  See our Note 1 in our unaudited financial statements for the three months ended March 31, 2013, as set forth herein.


Liquidity and Capital Resources


For the three months ended March 31, 2013


During the three months ended March 31, 2013, net cash used in operating activities was $536,153 and net cash used in investing activities was $97,093, which was due primarily to the Company’s research and development activities and general and administrative expenditures.  Net cash provided by financing activities for the three months ended March 31, 2013 was $1,015,625.  At March 31, 2013, our cash and cash equivalents totaled $3,319,258, our assets totaled $4,254,650, our liabilities totaled $210,976, and we had stockholders’ equity of $4,043,674.



-37-






Sources and Uses of Cash

Our future expenditures and capital requirements will depend on numerous factors, including: the progress of our research and development efforts; the rate at which we can, directly or through arrangements with original equipment manufacturers, introduce and sell products incorporating our polymer materials technology; the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; market acceptance of our products and competing technological developments; and our ability to establish cooperative development, joint venture and licensing arrangements.  We expect that we will incur approximately $3,000,000 of expenditures over the next 12 months.  Our cash requirements are expected to increase at a rate consistent with the Company’s path to revenue growth as we expand our activities and operations with the objective of commercializing our electro-optic polymer technology during 2013. We continue to develop and test our next generation electro-optic and third-order material platform to support and cultivate potential customers, strategic partners and develop photonic devices.  Management believes our initial revenue stream will be in prototype devices, application and non-recurring engineering charges, and material charges for specialty non-linear application prior to moving into full commercialization and production.

Our business does not presently generate the cash needed to finance our current and anticipated operations. Presently, our Company has a cash position of approximately $3,600,000; based upon our current cash position and expenditures of approximately $250,000 per month and no debt service, management believes we have sufficient funds currently to finance our operations through June 2014.  We plan to continue obtaining additional financing, now and in the future, until such time that we can conduct profitable revenue-generating activities.

Such future sources of financing may include cash from equity offerings, exercise of stock options, warrants and proceeds from debt instruments; but we cannot assure you that such equity or borrowings will be available or, if available, will be at rates or prices acceptable to us.

In May 2011 we signed our stock purchase agreement with Lincoln Park whereby subject to certain conditions and at our sole discretion, Lincoln Park has committed to purchase up to $20 million of our common stock over a 30-month period. We registered for resale by Lincoln Park 10,000,000 shares of our common stock in June 2011. Lincoln Park is obligated to make purchases as the Company directs in accordance with the purchase agreement, which may be terminated by the Company at any time, without cost or penalty. Sales of shares will be made in specified amounts and at prices that are based upon the market prices of our Company's common stock immediately preceding the sales to Lincoln Park. We expect this financing to provide our Company with sufficient funds to maintain its operations for the foreseeable future. With the additional capital, we expect to achieve a level of revenues attractive enough to fulfill our development activities and adequate enough to support our business model for the foreseeable future.  We cannot assure you that we will meet the conditions of the stock purchase agreement with Lincoln Park in order to obligate Lincoln Park to purchase our shares of common stock. In the event we fail to do so, and other adequate funds are not available to satisfy either short-term or long-term capital requirements, or if planned revenues are not generated, we may be required to substantially limit our operations. This limitation of operations may include reductions in capital expenditures and reductions in staff and discretionary costs. The purchase agreement expires in December 2013.



-38-






There are no trading volume requirements or restrictions under the purchase agreement, and we will control the timing and amount of any sales of our common stock to Lincoln Park. Lincoln Park has no right to require any sales by us, but is obligated to make purchases from us as we direct in accordance with the purchase agreement. We can also accelerate the amount of common stock to be purchased under certain circumstances. There are no limitations on use of proceeds, financial or business covenants, restrictions on future funding, rights of first refusal, participation rights, penalties or liquidated damages in the purchase agreement. We may terminate the purchase agreement at any time, at our discretion, without any penalty or cost to us. Lincoln Park may not assign or transfer its rights and obligations under the purchase agreement.


We expect that our cash used in operations will increase during 2013 and beyond as a result of the following planned activities:


·

The addition of management, sales, marketing, technical and other staff to our workforce;

·

Increased spending for the expansion of our research and development efforts, including purchases of additional laboratory and production equipment;

·

Increased spending in marketing as our products are introduced into the marketplace;

·

Developing and maintaining collaborative relationships with strategic partners;

·

Developing and improving our manufacturing processes and quality controls; and

·

Increases in our general and administrative activities related to our operations as a reporting public company and related corporate compliance requirements.


Analysis of Cash Flows


For the three months ended March 31, 2013


Net cash used in operating activities was $536,153 for the three months ended March 31, 2013, primarily attributable to the net loss of $922,471 adjusted by $38,934 in warrants issued for services, $230,990 in options issued for services, $19,550 in common stock issued for services, $26,328 in depreciation expenses and patent amortization expenses, $14,868 in prepaid expenses and $55,648 in accounts payable and accrued expenses.  Net cash used in operating activities consisted of payments for research and development, legal, professional and consulting expenses, rent and other expenditures necessary to develop our business infrastructure.


Net cash used by investing activities was $97,093 for the three months ended March 31, 2013, consisting of $10,722 in cost for intangibles and $86,371 in asset additions primarily for the new lab facility.


Net cash provided by financing activities was $1,015,625 for the three months ended March 31, 2013 and consisted of $1,000,000 proceeds from the sale of common stock to an institutional investor and $15,625 from the exercise of warrants.


Inflation and Seasonality


We do not believe that our operations are significantly impacted by inflation. Our business is not seasonal in nature.



-39-






Item 4

Controls and Procedures


Evaluation of Disclosure Controls and Procedures. The Company’s management, with the participation of the Company’s Principal Executive Officer and Principal Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of March 31, 2013.  Based on this evaluation, the Company’s Principal Executive Officer and Principal Financial Officer concluded that, as of March 31, 2013 the Company’s disclosure controls and procedures were effective, in that they provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and is accumulated and communicated to the Company’s management, including the Company’s Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.


Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting during the quarter ended March 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


PART II – OTHER INFORMATION


Item 2

Unregistered Sales of Equity Securities and Use of Proceeds


Date

Security/Value

March 2013

Option grant - 75,000 shares of common stock at $1.16 per share issued for services.  The option was valued at $81,076 using the Black-Scholes Option Pricing Formula.

March 2013

Warrant exercise - 12,500 shares of common stock purchased at $1.25 for proceeds of $15,625.


No underwriters were utilized and no commissions or fees were paid with respect to any of the above transactions. We relied on Section 4(2) of the Securities Act of 1933, as amended, since the transactions did not involve any public offering.




-40-






Item 6

Exhibits


The following exhibits are included herein:


Exhibit No.

Description of Exhibit

10.1

Purchase Agreement, dated as of May 3, 2011, by and between the Company and Lincoln Park Capital Fund, LLC (incorporated by reference to our Form 8-K filed on May 6, 2011).

10.2

Registration Rights Agreement, dated as of May 3, 2011, by and between the Company and Lincoln Park Capital Fund, LLC (incorporated by reference to our Form 8-K filed on May 6, 2011).

31.1

Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, executed by the Principal Executive Officer of the Company.

31.2

Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, executed by the Principal Financial Officer of the Company.

32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by the Principal Executive Officer of the Company.

32.2

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by the Principal Financial Officer of the Company.

101

The following financial information from Lightwave Logic Inc.'s Quarterly Report on Form 10-Q for the quarter ended March 31, 2013, formatted in XBRL (eXtensible Business Reporting Language): (i) Balance Sheets; (ii) Statements of Operations; (iii) Statement of Stockholders’ Equity; (iv) Statements of Cash Flows; and (v) Notes to Financial Statements.




-41-






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

LIGHTWAVE LOGIC, INC.


Registrant


By: /s/ Thomas E. Zelibor
Thomas E. Zelibor,

Chief Executive Officer

(Principal Executive Officer)

Date:  May 15, 2013


By: /s/ Thomas E. Zelibor
Thomas E. Zelibor,

Chief Executive Officer

(Principal Executive Officer)

Date:  May 15, 2013


By: /s/ James S. Marcelli
James S. Marcelli,

President, Chief Operating Officer

(Principal Financial Officer)


Date:  May 15, 2013




-42-



TABLE OF CONTENTS